Impact of gender on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty L Grinfeld, J Belardi, AJ Lansky, B Witzenbichler, G Guagliumi, K Zmudka, M Moeckel, A Ochala, W Ruzyllo, H - PowerPoint PPT Presentation

1 / 7
About This Presentation
Title:

Impact of gender on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty L Grinfeld, J Belardi, AJ Lansky, B Witzenbichler, G Guagliumi, K Zmudka, M Moeckel, A Ochala, W Ruzyllo, H

Description:

L Grinfeld, J Belardi, AJ Lansky, B Witzenbichler, G Guagliumi, K Zmudka, M ... Similar or reduced rates of NACE at 30 days. Similar or reduced rates of major bleeding ... – PowerPoint PPT presentation

Number of Views:39
Avg rating:3.0/5.0

less

Transcript and Presenter's Notes

Title: Impact of gender on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty L Grinfeld, J Belardi, AJ Lansky, B Witzenbichler, G Guagliumi, K Zmudka, M Moeckel, A Ochala, W Ruzyllo, H


1
Impact of gender on the safety and effectiveness
of bivalirudin in patients with acute myocardial
infarction undergoing primary angioplastyL
Grinfeld, J Belardi, AJ Lansky, B Witzenbichler,
G Guagliumi, K Zmudka, M Moeckel, A Ochala, W
Ruzyllo, H Parise, R Mehran, GW Stone
2
Objectives
  • To evaluate the impact of gender on the safety
    and effectiveness of bivaliridun monotherapy
    compared to UFH the routine use of GP IIb/IIIa
    inhibitors in patients with AMI undergoing
    primary angioplasty
  • Similar or reduced rates of NACE at 30 days
  • Similar or reduced rates of major bleeding

Grinfeld et al ACC 2008
3
Demographics
Male (N2760) Female (N842) p value
Age (years) 58.8 51.4, 67.8 66.0 57.1, 75.3 lt 0.0001
BMI 27.1 24.7, 30.0 26.7 24.0, 30.8 0.2
Diabetes 15.8 18.7 0.05
Hypertension 50.8 62.3 lt 0 0001
Hyperlipidemia 42.1 46.1 0.04
Current smoking 47.8 40.8 0.0004
Prior MI 12.0 7.4 0.0002
Prior PCI 11.6 7.9 0.002
Prior CABG 3.3 1.8 0.03
Grinfeld et al ACC 2008
4
Events by gender
Male (N2760) Female (N842) p value
1 Endpoint (MACE or major bleeding) 9.2 15.6 lt 0.0001
MACE (death, MI, ischemic TVR or stroke) 4.9 7.4 0.006
Death 2.2 3.8 0.01
Reinfarction 1.8 2.1 0.6
Stroke 0.6 0.8 0.5
Ischemic TVR 2.0 3.4 0.02
Major bleeding (Non-CABG related) 5.7 10.1 lt 0.001
Minor bleeding 7.8 14.3 lt 0.0001
Grinfeld et al ACC 2008
5
Events by gender (male)
RR0.77 0.59, 0.97 P0.03
RR0.59 0.43, 0.82 P0.001
P ns
Grinfeld et al ACC 2008
6
Events by gender (female)
RR0.76 0.54, 1.08 P0.01
RR0.59 0.38, 0.92 P0.02
P ns
Grinfeld et al ACC 2008
7
Conclusions
  • Women and men with AMI undergoing PCI have
    different risk profiles.
  • Women have a higher incidence of death, ischemic
    TVR, major and minor bleeding.
  • Despite these differences, bivalirudin
    monotherapy significantly reduces major bleeding
    and net adverse clinical events compared to UFH
    plus the routine use of GP IIb/IIIa inhibitors
    both in women and men.

Grinfeld et al ACC 2008
Write a Comment
User Comments (0)
About PowerShow.com